Atria Wealth Solutions’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Atria Wealth Solutions's LLY Position: Q2 2025 in Review
Atria Wealth Solutions reduced its Eli Lilly (LLY) stake by 66% in Q2 2025, selling an estimated $19.6M and leaving 12,987 shares worth $10.1M. The position accounts for 0.23% of the portfolio, ranked #99.
Atria Wealth Solutions first reported a position in LLY in Q1 2022 and has held it in 14 quarters since. The position peaked at $39.3M in Q2 2024. 3,907 funds tracked by Wall St. Rank hold LLY as of Q2 2025.
- Atria Wealth Solutions held 12,987 shares of Eli Lilly worth $10.1M as of Q2 2025.
- Atria Wealth Solutions sold 25,286 Eli Lilly shares in Q2 2025, an estimated $19.6M.
- Eli Lilly made up 0.23% of Atria Wealth Solutions's portfolio in Q2 2025, its #99 holding.
- Atria Wealth Solutions first reported a position in Eli Lilly in Q1 2022 and has held it in 14 quarters since.
- Atria Wealth Solutions's Eli Lilly position peaked at $39.3M in Q2 2024.
- 3,907 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2025.
Based on Atria Wealth Solutions's 13F filing for Q2 2025, filed 25 Jul 2025.